- Home
- CNP vs BNTX Comparison
CNP vs BNTX Comparison
Compare CNP & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CNP | BNTX |
|---|---|---|
| Founded | 1866 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.6B | 24.2B |
| IPO Year | 2001 | 2019 |
Fundamental Metrics
Financial Performance| Metric | CNP | BNTX |
|---|---|---|
| Price | $44.97 | $91.24 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 13 |
| Target Price | $44.08 | ★ $133.46 |
| AVG Volume (30 Days) | ★ 5.6M | 976.7K |
| Earning Date | 04-23-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.15% | N/A |
| EPS Growth | ★ 1.27 | N/A |
| EPS | ★ 0.48 | N/A |
| Revenue | ★ $9,357,000,000.00 | N/A |
| Revenue This Year | $7.02 | N/A |
| Revenue Next Year | $4.93 | $3.37 |
| P/E Ratio | $92.07 | ★ N/A |
| Revenue Growth | ★ 8.26 | N/A |
| 52 Week Low | $35.46 | $79.81 |
| 52 Week High | $44.49 | $124.00 |
Technical Indicators
Market Signals| Indicator | CNP | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.71 | 47.52 |
| Support Level | $41.47 | $87.53 |
| Resistance Level | N/A | $94.20 |
| Average True Range (ATR) | 0.87 | 2.26 |
| MACD | 0.23 | 0.34 |
| Stochastic Oscillator | 96.07 | 61.42 |
Price Performance
Historical ComparisonAbout CNP CenterPoint Energy Inc (Holding Co)
CenterPoint Energy owns a portfolio of businesses. Its regulated electric utilities provide transmission and distribution services to more than 2.5 million customers in the Houston area, southern Indiana, and west central Ohio.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens and neoantigens; monospecific and bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.